Profile:
Dr. Ma is a standing committee member of the Oncology Chemotherapy Committee of the Shaanxi Health Care Association and of the Shaanxi Society of Rehabilitation Medicine; a member of the Chemotherapy Committee of the Shaanxi Anti-Cancer Association, the Shaanxi Expert Committee for the Diagnosis and Treatment of Malignant Serous Cavity Effusions, and the Oncology Committee of the Shaanxi Research Hospital Association; and an editorial board member of Clinical Research and Practice. Dr. Ma has published more than 30 papers in core academic journals and one monograph.
Dr. Ma specializes in developing standardized treatment regimens involving radiotherapy, chemotherapy, endocrine therapy, targeted therapy, and immunotherapy for cancers affecting multiple organ systems, including lung cancer, breast cancer, gynecologic cancers, gastrointestinal cancers, urinary tract cancers, and malignant melanoma.
Dr. Ma has expertise in the comprehensive management of advanced unresectable tumors through local cytoreductive therapies, including CyberKnife, Gamma Knife, radioactive seed implantation, radiotherapy, cryoablation or thermal ablation, yttrium-90 therapy, and proton therapy, in combination with systemic treatment. Dr. Ma also has extensive experience in symptom management throughout the course of care for advanced cancer, including nutritional support, palliative pain relief, and management of complications, enabling the development of individualized precision treatment plans tailored to each patient.